These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34787459)

  • 1. Protein-RNA Interactome Analysis Reveals Wide Association of Kaposi's Sarcoma-Associated Herpesvirus ORF57 with Host Noncoding RNAs and Polysomes.
    Alvarado-Hernandez B; Ma Y; Sharma NR; Majerciak V; Lobanov A; Cam M; Zhu J; Zheng ZM
    J Virol; 2022 Feb; 96(3):e0178221. PubMed ID: 34787459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolism.
    Sei E; Wang T; Hunter OV; Xie Y; Conrad NK
    PLoS Pathog; 2015 Feb; 11(2):e1004652. PubMed ID: 25710169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLIP-seq to Identify KSHV ORF57-Binding RNA in Host B Cells.
    Ma Y; Liu P; Majerciak V; Zhu J; Zheng ZM
    Curr Protoc Microbiol; 2016 May; 41():1E.11.1-1E.11.18. PubMed ID: 27153386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182.
    Sharma NR; Majerciak V; Kruhlak MJ; Yu L; Kang JG; Yang A; Gu S; Fritzler MJ; Zheng ZM
    Nucleic Acids Res; 2019 Sep; 47(17):9368-9385. PubMed ID: 31400113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiftless Restricts Viral Gene Expression and Influences RNA Granule Formation during Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Rodriguez W; Mehrmann T; Hatfield D; Muller M
    J Virol; 2022 Nov; 96(22):e0146922. PubMed ID: 36326276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ORF57 overcomes the detrimental sequence bias of Kaposi's sarcoma-associated herpesvirus lytic genes.
    Vogt C; Hackmann C; Rabner A; Koste L; Santag S; Kati S; Mandel-Gutfreund Y; Schulz TF; Bohne J
    J Virol; 2015 May; 89(9):5097-109. PubMed ID: 25694606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-Mediated Knockout and
    BeltCappellino A; Majerciak V; Lobanov A; Lack J; Cam M; Zheng ZM
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of cellular export factor REF/Aly by Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is not required for efficient KSHV lytic replication.
    Li DJ; Verma D; Swaminathan S
    J Virol; 2012 Sep; 86(18):9866-74. PubMed ID: 22761374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's Sarcoma-Associated Herpesvirus K8 Is an RNA Binding Protein That Regulates Viral DNA Replication in Coordination with a Noncoding RNA.
    Liu D; Wang Y; Yuan Y
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA.
    Massimelli MJ; Majerciak V; Kruhlak M; Zheng ZM
    J Virol; 2013 Jan; 87(1):243-56. PubMed ID: 23077296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KSHV ORF57, a protein of many faces.
    Majerciak V; Zheng ZM
    Viruses; 2015 Feb; 7(2):604-33. PubMed ID: 25674768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation.
    Sharma NR; Majerciak V; Kruhlak MJ; Zheng ZM
    PLoS Pathog; 2017 Oct; 13(10):e1006677. PubMed ID: 29084250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's Sarcoma-Associated Herpesvirus Fine-Tunes the Temporal Expression of Late Genes by Manipulating a Host RNA Quality Control Pathway.
    Ruiz JC; Devlin AM; Kim J; Conrad NK
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The KSHV RNA regulator ORF57: target specificity and its role in the viral life cycle.
    Vogt C; Bohne J
    Wiley Interdiscip Rev RNA; 2016; 7(2):173-85. PubMed ID: 26769399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1.
    Massimelli MJ; Kang JG; Majerciak V; Le SY; Liewehr DJ; Steinberg SM; Zheng ZM
    Int J Biol Sci; 2011; 7(8):1145-60. PubMed ID: 22043172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein.
    Verma D; Li DJ; Krueger B; Renne R; Swaminathan S
    J Virol; 2015 Feb; 89(3):1688-702. PubMed ID: 25410858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export.
    Nekorchuk M; Han Z; Hsieh TT; Swaminathan S
    J Virol; 2007 Sep; 81(18):9990-8. PubMed ID: 17609285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple regions of Kaposi's sarcoma-associated herpesvirus ORF59 RNA are required for its expression mediated by viral ORF57 and cellular RBM15.
    Massimelli MJ; Majerciak V; Kang JG; Liewehr DJ; Steinberg SM; Zheng ZM
    Viruses; 2015 Feb; 7(2):496-510. PubMed ID: 25690794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus ORF57 protein protects viral transcripts from specific nuclear RNA decay pathways by preventing hMTR4 recruitment.
    Ruiz JC; Hunter OV; Conrad NK
    PLoS Pathog; 2019 Feb; 15(2):e1007596. PubMed ID: 30785952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based screening assay for antiviral compounds targeting the ability of herpesvirus posttranscriptional regulatory proteins to stabilize viral mRNAs.
    Verma D; Kim EA; Swaminathan S
    J Virol; 2013 Oct; 87(19):10742-51. PubMed ID: 23903829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.